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were body mass index (BMI), abdominal obesity, a family history of
cardiovascular disease among ﬁrst-degree relatives, a personal history
of diabetes, and high TG.
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OBJECTIVES We aimed to explore the appropriate WHR cutoffs to
identify people at high risk of cardiovascular disease of Uygur adults
in Xinjiang.
METHODS The cardiovascular risk survey(CRS) in Xinjiang was con-
ducted from October 2007 to March 2010, using 4-stagestratiﬁed random
sampling method to select 14618 representative participants, and the
questionnaire survey, anthropometric data, blood pressure, serum con-
centration of serum total cholesterol, triglyceride, low density lipopro-
tein (LDL), high density lipoprotein (HDL) and fasting glucose were
documented. A total of 4767 Uyghur people were selected and completed
the study. The present statistical analysis was restricted to the 4657
adults between 35 and 101 years old who had complete anthropometric
data. The sensitivity, speciﬁcity and distance on the receiver operating
characteristic (ROC) curve of different WHR levels predicting risk factors
of cardiovascular disease were calculated. The analysis method of ROC
curve was used to determine the optimum cut-off point of WHR pre-
dicting risk factors of cardiovascular disease.
RESULTS (1) The prevalence of hypertension, hypercholesterolemia
and hypertriglyceridemia were higher with higher WHR for both men
and women. While the prevalence of diabetes, high LDL, low HDL did
not show obvious trend both in men and women.
(2) The shortest distance in the ROC curves for hypertension, dys-
lipidemia, diabetes and 2 of these risk factors suggested a WHR
cutoff of 0.92 for men and 0.90 for women.
CONCLUSIONS Higher WHR cutoffs are needed in the identiﬁcation
of people at high risk of cardiovascular disease among Uygur adults in
Xinjiang.
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OBJECTIVES To learn the status of the cardiovascular disease asso-
ciated risk levels among Xinjiang Han, Uygur and Kazakh hyperten-
sive population.
METHODS Using the four stages stratiﬁed random sampling method,
all the data was collected from local residents age large than 18,
subjects information include lifestyle, physical examination and lab-
oratory examination results from 2007 to 2010.
RESULTS There is 15061 subjects accomplish this survey, in which
2654 Han, 1612 Uygur and 2034 Kazakh people diagnosed with hy-
pertension, Most of them were “grade one hypertension”. Cardio-
vascular disease related risk factors respectively in Han, Uygur and
Kazakh, include older age (39.3%, 38.0%, 30.9%), smoking (33.2%,
20.1%, 32.4%), abnormal fasting glucose (10.4%, 6.5%, 8.0%),
abnormal TC (19.4%, 13.6%, 24.7%), obesity (26.0%, 39.8%, 46.3%).
Majority hypertensive people accompany with 1 risk factor. The risk
proportions of low, medium, high and very high in hypertension
population of different ethnicities respectively is Han (19.4%, 34.6%,
18.8%, 27.3%), Uygur (17.7%, 37.6%, 17.3%, 27.4%) and Kazakh (12.5%,
38.0%, 31.1%, 18.3%). Most proportion of hypertension people in high
risk and very high risk situation, the medium risk hypertension pop-
ulation proportion in female were also very large. In the aware group,
the medium risk population is mostly. In the group without therapy,
medium risk, high risk and very high risk proportion were similar
high, The cardiovascular disease risk stratiﬁcation in age, gender,
aware or unaware of disease, medicine therapy or not have signiﬁcant
difference in different ethnicities of hypertension population.
CONCLUSIONS The cardiovascular disease risk-related levels in Xinjiang
hypertension population have difference between Han, Uygur and Kazakhethnicities, most of hypertension population under high risk and very high
risk of situation, especially in those age 60, males population. In female,
medium risk population proportion were also very high.
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OBJECTIVES To evaluate the prevalence of atrial ﬁbrillation (AF) in
physical laborers in rural China and identify contributing risk factors.
METHODS A cross-sectional study of 11,956 permanent residents of
Liaoning Province in rural China  35 y of age (primarily physical laborers)
was conducted between January and August 2013 (response rate 85.3%).
All participants completed a questionnaire and underwent a physical
exam, echocardiography and electrocardiography. Blood samples were
drawn for laboratory analyses, and AF was diagnosed on the basis of
history and electrocardiograph ﬁndings. Risk factors for AF were evalu-
ated with a stepwise logistic regression analysis.
RESULTS The prevalence of AF was 1.2% overall, but rose steeply with
age (0.1% in those 35–44 y of age, and 4.6% in those  75 y); there was no
signiﬁcant gender difference at any age. Independent risk factors for AF
were age (odds ratio [OR] 1.89; P < 0.001), diabetes (OR 2.07; P ¼ 0.001),
history of myocardial infarction (OR 5.91; P < 0.001), low left ventricular
ejection fraction (OR 1.85; P ¼ 0.005), and low physical activity (OR 1.72;
P ¼ 0.003), whereas obesity, hypertension, cholesterol and triglyceride
levels, current smoking and drinking, left ventricular hypertrophy, and
family history of AF were not signiﬁcant contributors.
CONCLUSIONS Although the prevalence of AF in physical labors in
rural China is low, age, diabetes, history of myocardial infarction, low
left ventricular ejection fraction, and low physical activity are inde-
pendent risk factors.
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OBJECTIVES Levels of ambient ﬁne particulate matter (PM2.5) in China
are among the highest in the world. Black carbon (BC) is an important
component of PM2.5, which has been associated more strongly than has
PM2.5 with the adverse health effects. To our knowledge, few studies have
been conducted to differentiate the associations of PM2.5 and black carbon
on blood pressure (BP) and hypertensive disorders of pregnancy (HDP).
We aim to explore acute effects of Black Carbon and PM2.5 on blood
pressure in the third trimester of pregnancy so as to provide clues for
further studies on HDP and air quality indicators in China.
METHODS The health data came from a cohort study on prevalence of
HDP and gestational diabetes in Shanghai City in 2010. The environ-
mental data obtained from Shanghai Key Laboratory of Meteorology
and Health. A total 7408 pregnant women were included in the study.
We applied generalized additive mixed model to examine the asso-
ciations of air pollutants and blood pressure. The exposure variables
were PM2.5, BC on the same day (1-day average) and 3- to 5-day av-
erages, and the outcome variables were systolic blood pressure (SBP),
diastolic blood pressure (DBP) measured in the third trimester. The
nonlinear covariates of daily temperature and humidity were adjusted
by natural cubic regression splines. All statistical analyses were per-
formed using R Statistical Software, version R 2.15.1.
RESULTS In one-pollutant model, after adjustment for maternal age,
nulliparity, multiple birth, BMI at ﬁrst perinatal visit, family history of
hypertension, and other chronic disease, history of abnormal preg-
nancy, and daily temperature and humidity, we found IQR increases
3-day and 5-day average PM2.5 may induce 0.38 mmHg (95% CI, 0.12 to
0.64), 0.30 mmHg (95%CI, 0.03, 0.57) increases in SBP. IQR increases
in 1-day, 3-day and 5-day average BC predicted 0.49 mmHg (95%CI,
0.21 to 0.78), 0.48 mmHg(95% CI,0.19 to 0.76), and 0.50 mmHg (95%
CI,0.21, 0.79) increases in SBP. We also observed the similar ﬁndings
in DBP, 3-day and 5-day average PM2.5 increased 0.52 mmHg (95%CI,
0.07 to 0.98), 0.48 mmHg (95%CI, 0.02, 0.93); and BC increased
C120 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 50.55 mmHg (95%CI, 0.06 to 1.04), 0.54 mmHg (95% CI,0.04 to 1.03),
0.59 mmHg (95%CI, 0.09 to 1.09). However, in two-pollutant model
(PM2.5, BC), only IQR increases in 1-day(0.57 mmHg, 95%CI, 0.18 to
0.96) average BC was related signiﬁcantly with SBP, and 5-day average
BC (0.49 mmHg, 95% CI, 0.11 to 0.87) with DBP.
CONCLUSIONS In conclusion, our study suggests that PM2.5 and BC
are related with blood pressure of pregnant women in China, repre-
senting possibly increased risk of HDP. BC was more strongly associ-
ated with BP of pregnancy. In vitro and vivo studies also reported that
BC stimulates reactive oxygen species production and cytokine-
mediated inﬂammation, which may play a role in the BP and HDP. Our
study suggests combustion associated particles are particularly
important in China. Black carbon should be considered as one of the
air quality indicators in China.
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OBJECTIVES This study was intended to evaluate the efﬁcacy and
safety of Tongxinluo capsule for hypertension.
METHODS We searched the Cochrane Central Register of Controlled Tri-
als (CENTRAL) in the Cochrane Library, MEDLINE, Chinese Bio-Medical
Literature Database (CBM), Chinese National Knowledge Infrastructure
(CNKI), Wan-fang Data started from the ﬁrst of database to 1, 2015. No
language restriction was applied. We included randomized clinical trials
testing Tongxinluo capsule against western medicine, Tongxinluo capsule
versus placebo, Tongxinluo capsule combined with western medicine
versus western medicine and Tongxinluo capsule combined with western
medicine versus western medicine combined with placebo. Study selec-
tion, data extraction, quality assessment, and data analyses were con-
ducted according to the Cochrane standards.
RESULTS 30 trials with 2903 participants were included. The methodo-
logical quality of the included trials was evaluated as generally low. The
BP-lowering effect of Tongxinluo capsule plus western medicine was
signiﬁcantly higher than that of western medicine (SBP: -4.19, -5.70 to
-2.68, P<0.00001, DBP: -2.43, -3.77 to -1.08, P¼0.0004) or western medi-
cine combined with placebo (SBP: -1.95, -2.37 to -1.53, P<0.00001; DBP:
-0.32, -0.62 to -0.02, P ¼0.04). The BP also decreased signiﬁcantly from
baseline with Tongxinluo capsule than placebo (SBP: -9.40, -10.90 to
-7.90, P < 0.00001; DBP: -11.80, -12.40 to -11.20, P < 0.00001) or western
medicine (SBP: -3.90,-4.93 to -2.87, P < 0.00001; DBP: -3.70, -3.83 to -3.57,
P < 0.00001).12 trials reported adverse events without details.
CONCLUSIONS The current clinical evidence is not of sufﬁcient
quality for wider application of Tongxinluo capsule to be recom-
mended for the treatment of hypertension, and further large, rigor-
ously designed trials are warranted.
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OBJECTIVES To evaluation the efﬁcacy and safety of Traditional
Chinese medicine injections in patients with AMI.
METHODS We searched the Cochrane library (Issue 4, 2011), Pubmed
(1966 to 2011), EMbase (1978 to 2011), CBM (1979 to 2011), CNKI (1979 to
2011) and VIP (1989 to 2011). Randomized controlled trials (RCTs)
comparing either Traditional Chinese Medicine injections only or routine
treatment plus Traditional Chinese Medicine injections with routine
treatment or placebo or no intervention were included. Study selection
and meta-analysis were conducted according to the Cochrane Handbook
for systematic review. Data were extracted from these trials by 3 reviewers
independently and analyzed by RevMan5.1 software.
RESULTS Twenty-one trials involving a total of 1713 AMI patients were
included. The studies provided support of a beneﬁt of Traditional Chinese
Medicine injections combined with routine therapy for reducing the
incidence of mortality [RR¼0.53, 95% CI(0.30, 0.93), P¼0.03], arrhythmia
[RR¼0.42, 95%CI (0.22, 0.80), P¼0.008], heart failure [RR¼0.31, 95%
CI(0.16, 0.61), P¼0.0007] when compared to routine therapy. No evidence
was found for superiority of Traditional Chinese Medicine injections
combined with routine therapy for increasing the rate of recanalization
and reducing the incidence of cardiogenic shock compared to routine
therapy. No serious adverse events were reported.CONCLUSIONS This systematic review found that Traditional Chi-
nese medicine injections in combination with routine therapy may be
a useful treatment to reduce the mortality, arrhythmia and heart
failure of AMI. Due to the methodological limitations of the studies,
the evidence is insufﬁcient to make any conclusive recommendations
about the use of this treatment for patients presenting with AMI.
Large high quality randomized controlled trials are required.
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OBJECTIVES To evaluate the association between the G534A poly-
morphism in the 11-bHSD gene and susceptibility to essential hyper-
tension (EH).
METHODS Based on comprehensive searches of PubMed, Embase,
Google Scholar, CBM, CNKI, WF and CQVIP databases, we identiﬁed
and abstracted outcome data from all articles before March 2015. The
pooled odds ratios (ORs) with 95% conﬁdence intervals (CIs) were
performed in all genetic models. Fixed or random effects model was
separately used depending on the heterogeneity between studies.
Publication bias was tested by Egger’s linear regression approach and
Begg rank correlation test.
RESULTS A total of 1969 cases and 1126 controls accorded inclusion criteria
for detailed analysis. Result in all genetic models: (allelic model: G vs. A :
OR ¼ 0.996, 95%CI¼0.924-1.074, P¼0.916;co-dominant model: GGvs. AA:
OR ¼ 1.022,95%CI¼0.889-1.131, P¼0.968; dominant model: GGþGA
vs.AA:OR¼1.002,95%CI¼0.894-1.124, P¼0.970;recessive model: GGvs.
GAþAA :OR ¼ 1.003, 95 % CI ¼ 0.900-1.117, P¼0.963), all P values>0.05.
CONCLUSIONS The present meta-analysis suggested that 11-bHD
gene-G534A polymorphism was unlikely contribute to essential
hypertension susceptibility.
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OBJECTIVES To systematically assess the current clinical evidence of
Zhigancao (ZGC) Decoction for premature ventricular contractions
(PVCs).
METHODS ll been me and e databases nce.rm adverse eventsSearch
Strategy: PubMed, the Cochrane Center Controlled Trials Register,
EMBASE, Chinese National Knowledge Infrastructure, Chinese Scientiﬁc
Journal Database, and Wanfang Med Online Database were searched until
June 2014. We included randomized clinical trials testing ZGC Decoction
against anti-arrhythmic drugs, ZGC Decoction combined with anti-
arrhythmic drugs versus anti-arrhythmic drugs alone. Study selection, data
extraction, quality assessment, and data analyses were conducted ac-
cording to the Cochrane standards. A meta-analysis of improving total
effects and reducing number of ventricular premature beats was per-
formed to evaluate the effects of ZGC Decoction on PVCs.
RESULTS A total of 25 studies (involving 2441 patients) were included.
The methodological quality of the included trials was evaluated as
generally low. The results of the meta-analysis showed that ZGC
Decoction combined with anti-arrhythmic drugs had signiﬁcant effect on
improving total effects (RR: 1.30 [1.22, 1.38]; P < 0.00001) and relieving
number of ventricular premature beats (MD: -6.66 [-12.94, -0.37];
P¼0.04) compared with anti-arrhythmic drugs alone. Our review showed
that ZGC Decoction was more effective in improving total effects (RR: 1.22
[1.08, 1.37]; P¼0.0009), compared with anti-arrhythmic drugs alone. 13
trials reported adverse events, while the others did not mention them,
indicating that the safety of ZGC Decoction remains uncertain.
CONCLUSIONS ZGC Decoction appears to have beneﬁcial effects
on improvement of total effects, reduction of number of ventricular
premature beats in participants with PVCs. However, further
thorough investigation, large-scale, proper study designed, randomized
trials of ZGC Decoction for PVCs will be required to justify the effects
reported.
